Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PALISADE BIO, INC.

(PALI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about PALISADE BIO, INC.
08:01aPalisade Bio Announces the European Patent Office to Grant a Patent for its Lead Drug C..
AQ
11/23Palisade Bio Announces Inducement Awards Under Inducement Plan for Key New Hires, Inclu..
AQ
11/23PALISADE BIO, INC. : Change in Directors or Principal Officers, Submission of Matters to a..
AQ
11/15Palisade Bio Reports Third Quarter Financial Results
AQ
11/12PALISADE BIO, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
AQ
11/12Palisade Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended..
CI
10/28PALISADE BIO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
AQ
10/22PALISADE BIO : Announces Sale of Seneca Asset NSI-189 for the treatment of Central Nervous..
PU
10/22PALISADE BIO, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
10/22PALISADE BIO : to Sell Neurogenic Compound Previously Part of Seneca Biopharma's Product R..
MT
10/22PALISADE BIO : Announces Sale of Seneca Asset NSI-189 for the Treatment of Central Nervous..
AQ
09/13PALISADE BIO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
AQ
09/09PALISADE BIO : to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Con..
AQ
08/31PALISADE BIO : Maxim Starts Palisade Bio at Buy With $7 Price Target
MT
08/24Palisade Bio Reports Second Quarter Financial Results and Provides Business Update
GL
08/24Palisade Bio, Inc. Announces Unaudited Earnings Results for the Second Quarter and Six ..
CI
08/24PALISADE BIO : Entry into a Definitive Material Agreement (Form 8-K)
PU
08/24PALISADE BIO, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equi..
AQ
08/23PALISADE BIO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF ..
AQ
08/20PALISADE BIO : Secures $5.2 Million Investment From Yuma Regional Medical Center; Shares A..
MT
08/20PALISADE BIO : Announces $5.2M Investment by the Yuma Regional Medical Center
AQ
08/20Palisade Bio, Inc. announced that it has received $5.209141 million in funding from Yum..
CI
07/29PALISADE BIO : and Newsoara Announce Positive Topline Efficacy Results from Phase 2 Study ..
AQ
07/29Palisade Bio and Newsoara Announces Positive Topline Efficacy Results from Phase 2 Stud..
CI
07/22PALISADE BIO : Entry into a Definitive Material Agreement (Form 8-K)
PU
07/22PALISADE BIO, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equi..
AQ
07/13PALISADE BIO : Financial Statements and Exhibits (form 8-K/A)
AQ
07/13PALISADE BIO : Enters into Worldwide In-Licensing Agreement with University of California ..
AQ
07/09PALISADE BIO, INC. : Changes in Registrant's Certifying Accountant, Financial Statements a..
AQ
06/16PALISADE BIO : Securities Purchase Agreement (Form 8-K)
PU
06/16PALISADE BIO, INC. : Other Events (form 8-K)
AQ
06/15Palisade Bio Launches Clinical Steering Committee to Provide Clinical Oversight and Gui..
GL
06/15Palisade Bio, Inc. Launches Clinical Steering Committee
CI
06/01PALISADE BIO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
AQ
05/26PALISADE BIO : Unregistered Sales of Equity Securities (Form 8-K)
PU
05/26PALISADE BIO, INC. : Unregistered Sale of Equity Securities, Other Events (form 8-K)
AQ
05/14PALISADE BIO : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF ..
AQ
05/13Wall Street Futures Mostly Higher, Producer Prices Surge More Than Expected in April
MT
05/13US Futures Narrowly Mixed, Data Eyed
MT
05/13PALISADE BIO : Says Treatment to Reduce Post-Surgical Adhesions Wins Fast-Track Status Fro..
MT
05/13PALISADE BIO : Receives FDA Fast Track Designation for LB1148 for Reduction of Adhesions F..
AQ
05/13Palisade Bio Receives FDA Fast Track Designation for LB1148 for Reduction of Adhesions ..
CI
05/07Palisade Bio and Newsoara Announce Completion of Phase 2 Study in GI Surgery Study in C..
GL
05/07Palisade Bio and Newsoara Announce Completion of Phase 2 Study in GI Surgery Study in C..
CI
05/06PALISADE BIO, INC. : Other Events (form 8-K)
AQ
05/04PALISADE BIO : Hosting Key Opinion Leader Webinar on LB1148, an Oral Serine Protease Inhib..
AQ
04/28SENECA BIOPHARMA : Corporate Presentation
PU
04/28PALISADE BIO, INC. : Regulation FD Disclosure (form 8-K)
AQ
04/28PALISADE BIO, INC.(NASDAQCM : PALI) added to NASDAQ Composite Index
CI
04/28PALISADE BIO, INC. : REVERSE SPLIT: 1 of 6
FA
04/27PALISADE BIO, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition..
AQ
04/27Seneca Biopharma, Inc. Announces Board Changes
CI
04/27SENECA BIOPHARMA, INC.(NASDAQCM : SNCA) dropped from NASDAQ Composite Index
CI
04/27Palisade Bio, Inc. announced that it has received $20 million in funding from Altium Ca..
CI
04/27Leading BioSciences Inc completed the acquisition of Seneca Biopharma, Inc. in a revers..
CI
04/27Palisade Bio, Inc. Announces Board Changes
CI
04/26SECTOR UPDATE : Health Care Stocks Drifting Lower Near Monday Close
MT
04/26SENECA BIOPHARMA : Says Merger With Leading Biosciences Receives Final Approval
MT
04/26SENECA BIOPHARMA : Announces Successful Approval of Merger with Leading Biosciences, Inc.
PR
04/23SENECA BIOPHARMA : Submission of Matters to a Vote of Security Holders (form 8-K/A)
AQ
04/20SENECA BIOPHARMA : Leading BioSciences Announces Early Efficacy Signal in Reducing Post-Su..
AQ
04/20Leading BioSciences Announces Early Efficacy Signal in Reducing Post-Surgical Adhesions..
CI
04/19SENECA BIOPHARMA : Leading BioSciences Provides Update to Seneca Biopharma, Inc. Stockhold..
AQ
04/19Leading BioSciences, Inc. Anticipates Announcing Data from A Phase 2 GI Surgery Study
CI
04/15SENECA BIOPHARMA : Submission of Matters to a Vote of Security Holders, Other Events (form..
AQ
04/12SENECA BIOPHARMA, INC. : Announces (i) Voting Results from the Special Meeting of Stockhol..
PR
04/09SENECA BIOPHARMA, INC. : Submission of Matters to a Vote of Security Holders, Other Events..
AQ
03/31Palisade Bio, Inc. announced that it expects to receive $20 million in funding from Alt..
CI
03/30SENECA BIOPHARMA : Stockholder Letter
PR
03/29SENECA BIOPHARMA : - LBS Letter to Stakeholders
PU
03/29SENECA BIOPHARMA : Biopharmaceuticals, Inc. - Special Meeting Q&A
AQ
03/26SENECA BIOPHARMA : Special Meeting Q&A
PR
03/24SENECA BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
03/24SENECA BIOPHARMA : Announces New Special Meeting Date of April 9, 2021
PR
03/23SENECA BIOPHARMA, INC. : Results of Operations and Financial Condition (form 8-K)
AQ
1  2  3  4Next